Abstract
Hexavalent chromium [Cr(VI)] is a well-established human lung carcinogen. Water solubility has proven to be a key factor in the carcinogenicity of Cr(VI), with the water insoluble or "particulate" compounds the more potent carcinogens. Pathology studies indicate that chromates target cells at bronchial bifurcation sites in human lungs. However, it is uncertain what roles particle internalization and dissolution play in the genotoxicity of these compounds to human lung cells. We investigated these mechanisms in a human lung cell line after exposure to particulate lead chromate. We found that lead chromate was clastogenic in a concentration-dependent manner with 0.1, 0.5, and 1 microg/cm(2), while 5 and 10 microg/cm(2) caused complete cell cycle arrest. We also found concentration-dependent increases in intracellular and extracellular chromium ion levels. We investigated particle internalization by using transmission electron microscopy and found an apparent relative increase with concentration but no apparent particle internalization at the lowest concentration (0.1 microg/cm(2)) even after 24 h. Furthermore, we found no lysosomal association with the vacuoles containing particles, further suggesting that intracellular dissolution did not occur. Cotreating the cells with lead chromate and vitamin C eliminated both the uptake of ionic chromium and the clastogenic activity of lead chromate but had no effect on particle internalization. These data indicate that in human bronchial cells lead chromate clastogenesis is mediated by the extracellular dissolution of the particles and not their internalization. These findings have important implications for our understanding of the physicochemical mechanism of particulate chromates as they contradict previous indirect data from human bronchial epithelial cells, which suggest that particles dissolve inside those cells. Thus, these new data suggest that there may be different mechanisms of genotoxicity for epithelial cells and fibroblasts exposed to chromate particles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.